Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability

Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability

Item
http://www.wikidata.org/entity/Q28260756
Vascular endothelial growth factor A: just one of multiple mechanisms for sex-specific vascular development within the testis?Vascular endothelial growth factor-B in physiology and diseaseStructural determinants of growth factor binding and specificity by VEGF receptor 2Structural Insights into the Binding of Vascular Endothelial Growth Factor-B by VEGFR-1D2: RECOGNITION AND SPECIFICITYA novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytesPlacental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disordersPlacenta growth factor: potential role in pregnancy.The discovery of placenta growth factor and its biological activity.Tying the knot: the cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines.The role of VEGF receptors in angiogenesis; complex partnershipsArg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism.VEGF receptor signaling in vertebrate development.Platelet-derived growth factors and their receptors: structural and functional perspectives.The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.The viral CC chemokine-binding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B-binding site.Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.VEGF inhibitor (Iressa) arrests histone deacetylase expression: single-cell cotransfection imaging cytometry for multi-target-multi-drug analysis.
P2860

Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability

Item
http://www.wikidata.org/entity/Q28260756
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Mapping the charged residues i ...... nding and structural stability
@ast
Mapping the charged residues i ...... nding and structural stability
@en
Mapping the charged residues i ...... nding and structural stability
@nl
type
label
Mapping the charged residues i ...... nding and structural stability
@ast
Mapping the charged residues i ...... nding and structural stability
@en
Mapping the charged residues i ...... nding and structural stability
@nl
prefLabel
Mapping the charged residues i ...... nding and structural stability
@ast
Mapping the charged residues i ...... nding and structural stability
@en
Mapping the charged residues i ...... nding and structural stability
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Mapping the charged residues i ...... nding and structural stability
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921